Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL AT INIST-CNRS Gene Section Mini Review DRAM (damage-regulated autophagy modulator) Michael J Spinella Department of Pharmacology, Dartmouth Medical School, 7650 Remsen, Hanover NH 03755, USA (MJS) Published in Atlas Database: April 2008 Online updated version: http://AtlasGeneticsOncology.org/Genes/DRAMID44093ch12q23.html DOI: 10.4267/2042/44422 This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. © 2009 Atlas of Genetics and Cytogenetics in Oncology and Haematology Expression Identity No expression data for endogenous DRAM is available at the protein level. Other names: FLJ11259 Location: 12q23.2 Local order: Cen-SYCP3-GNPTAB-DRAMLOC100129880-CCDC53-Tel. Localisation Overexpressed and tagged DRAM appears to localize to the lysosome. Localization of endo-genous DRAM has not been reported. DNA/RNA Function Description The major transcript is 3553 bp. An alternative, inframe spliced variant has been described that skips exon 4 and exon 5. Significance of this transcript is not known. DRAM mRNA is induced in a p53-dependent manner after cellular or genotoxic stress. Two alternative functional p53 consensus enhancer elements have been described. DRAM is also induced by p73. DRAM mRNA appears to be widely expressed in various tissues and cell types. DRAM mRNA is reported to be decreased in various tumor types compared to normal tissue. The precise function of DRAM is unknown. The first paper reporting a biologic activity for DRAM was in 2006. There is strong evidence from multiple sources that DRAM (FLJ11259) is a direct p53 target gene and is induced in response to DNA damage. This includes global p53-induced gene expression and global p53 ChIP-PET studies. DRAM is a mediator of autophagy and is required for p53-induced apoptosis in response to DNA damage. However, DRAM has minimal effects alone on cell growth or apoptosis. DRAM mRNA is downregulated in some tumors compared to normal. Overall evidence suggests DRAM may be a tumor suppressor downstream of p53. However, whether the role of DRAM in autophagy is positive or negative and whether DRAM mediates cell death or survival in pathologic and physiologic settings may be complex and context dependent. Pseudogene Homology Chromosome 4 (LOC727709). DRAM is highly conserved in higher metazoans including C. elegans, Drosophila, and Zebrafish. DRAM shares no homology with any proteins of known function. DRAM has no known functional domains. Human DRAM shares significant homology with other 6 transmembrane proteins of unknown function, including TMEM77, TMEM150 (TM6P1), and FLJ12993. TM6P1 was cloned by subtractive hybridization as induced in starved rat liver. Nutrient The gene encompasses 46.3 Kb of DNA and contains 7 exons. All exons are coding with exon 1 and exon 7 containing additional noncoding sequences at their 5' and 3' ends, respectively. Transcription Protein Description DRAM consists of 238 amino acids. It is predicted to have 6 transmembrane regions. DRAM is a lysosomal protein that is required for induction of autophagy by the p53 pathway. Atlas Genet Cytogenet Oncol Haematol. 2009; 13(3) 194 DRAM (damage-regulated autophagy modulator) Spinella MJ Crighton D, Wilkinson S, O'Prey J, Syed N, Smith P, Harrison PR, Gasco M, Garrone O, Crook T, Ryan KM. DRAM, a p53induced modulator of autophagy, is critical for apoptosis. Cell. 2006 Jul 14;126(1):121-34 starvation is a major physiologic inducer of autophagy. Mutations Green DR, Chipuk JE. p53 and metabolism: Inside the TIGAR. Cell. 2006 Jul 14;126(1):30-2 Note Have not been described. Autophagy Wei CL, Wu Q, Vega VB, Chiu KP, Ng P, Zhang T, Shahab A, Yong HC, Fu Y, Weng Z, Liu J, Zhao XD, Chew JL, Lee YL, Kuznetsov VA, Sung WK, Miller LD, Lim B, Liu ET, Yu Q, Ng HH, Ruan Y. A global map of p53 transcription-factor binding sites in the human genome. Cell. 2006 Jan 13;124(1):207-19 Note DRAM may be involved in diseases associated with deregulation of autophagy. DRAM may link p53 and cancer suppression/ treatment to autophagy. Crighton D, O'Prey J, Bell HS, Ryan KM. p73 regulates DRAMindependent autophagy that does not contribute to programmed cell death. Cell Death Differ. 2007 Jun;14(6):1071-9 References Crighton D, Wilkinson S, Ryan KM. DRAM links autophagy to p53 and programmed cell death. Autophagy. 2007 JanFeb;3(1):72-4 Implicated in Zhang J, D'Ercole AJ, Underwood LE. Identification of a new gene (rat TM6P1) encoding a fasting-inducible, integral membrane protein with six transmembrane domains. Biochim Biophys Acta. 2000 Jun 21;1492(1):280-4 Kerley-Hamilton JS, Pike AM, Hutchinson JA, Freemantle SJ, Spinella MJ. The direct p53 target gene, FLJ11259/DRAM, is a member of a novel family of transmembrane proteins. Biochim Biophys Acta. 2007 Apr;1769(4):209-19 Kerley-Hamilton JS, Pike AM, Li N, DiRenzo J, Spinella MJ. A p53-dominant transcriptional response to cisplatin in testicular germ cell tumor-derived human embryonal carcinoma. Oncogene. 2005 Sep 8;24(40):6090-100 Atlas Genet Cytogenet Oncol Haematol. 2009; 13(3) This article should be referenced as such: Spinella MJ. DRAM (damage-regulated autophagy modulator). Atlas Genet Cytogenet Oncol Haematol. 2009; 13(3):194-195. 195